Search results for " Transplant Recipients"
showing 7 items of 7 documents
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH sur…
2017
Background Scant information is available about how transplant centers are managing their use of quantitative molecular testing (QNAT) assays for active cytomegalovirus (CMV) infection monitoring in solid organ transplant (SOT) recipients. The current study was aimed at gathering information on current practices in the management of CMV infection across European centers in the era of molecular testing assays. Methods A questionnaire-based cross-sectional survey study was conducted by the European Study Group of Infections in Immunocompromised Hosts (ESGICH) of the Society of Clinical Microbiology and Infectious Diseases (ESCMID). The invitation and a weekly reminder with a personal link to …
Occult hepatitis B virus infection
2000
Many studies have shown that hepatitis B virus infection may also occur in hepatitis B surface antigen-negative patients. This occult infection has been identified both in patients with cryptogenic liver disease and in patients with hepatitis C virus-related chronic hepatitis, and much evidence suggests that it may be a risk factor of hepatocellular carcinoma development. However several aspects of this occult infection remain unclear such as its prevalence and the factor(s) involved in the lack of circulating hepatitis B surface antigen. Moreover, it is uncertain whether the occult hepatitis B virus infection may contribute to chronic liver damage, considering that it is usually associated…
Single center report on complications in steroid-free immunosuppressive therapy of liver transplant recipients
2010
Kardiovaskulārā riska izvērtējums pacientiem ar nieres transplantātu
2022
Viens no biežākajiem nāves iemesliem pacientiem ar funkcionējošu nieres transplantātu ir kardiovaskulāri (KV) notikumi. Lai savlaicīgi varētu veikt preventīvu ārstēšanu un uzlabot nieres transplantāta recipientu dzīvildzi, ir nozīmīgi izvērtēt svarīgākos KV riska faktorus un to ietekmi uz KV notikumu attīstību. Retrospektīva pētījuma mērķis bija izvērtēt KV notikumu incidenci, riska faktorus un nieres transplantācijas (NT) iznākumus pacientiem ar KV notikumiem. Pētījumā tika iekļauti 184 pacienti. Datu analīzei pacienti tika sadalīti divās grupās: pacienti ar KV notikumiem un pacienti bez KV notikumiem. Glomerulārās filtrācijas ātrums tika aprēķināts pēc CKD-EPI Creatinine, 2021 formulas. R…
Italian association for the study of the liver position statement on SARS-CoV2 vaccination.
2021
The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver dise…
AISF position paper on HCV in immunocompromised patients.
2018
Abstract This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.
Is COVID‐19 infection more severe in kidney transplant recipients?
2021
International audience; There are no studies which have compared the risk of severe Covid-19 and related mortality between transplant recipients and non-transplant patients. We enrolled two groups of patients hospitalized for Covid-19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a single-center cohort of non-transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covid-19 or mortality. Severe Covid-19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death.Transplant recipients were younger and had more comorbidities compared to…